APP669-711

Code:
4518-v
Name:
APP669-711
Val-Lys-Met-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val
(Trifluoroacetate Form)
(M.W. 4688.3) C210H325N57O61S2
A Factor of Plasma Biomarker for Cerebral Amyloid
Package Price(Yen) Availability
Vial 0.5 mg 30,000 Ships within
1-3 business days

main

Purity:
≧90.0% (HPLC)
Storage:
-20 ℃

more information

Category:
Biologically Active Peptides

reference

  1. N. Kaneko, R. Yamamoto, T. Sato, and K. Tanaka, Proc. Jpn. Acad. B, 90, 104 (2014). (Identification in plasma)
  2. N. Kaneko, A. Nakamura, Y. Washimi, T. Kato, T. Sakurai, Y. Arahata, M. Bundo, A. Takeda, S. Niida, K. Ito, K. Toba, K. Tanaka, and K. Yanagisawa, Proc. Jpn. Acad. B, 90, 353 (2014). (Correlation between APP669-711/Aβ1-42 in plasma and cerebral amyloid deposition)
  3. A. Nakamura, N. Kaneko, V.L. Villemagne, T. Kato, J. Doecke, V. Dore, C. Fowler, Q.X. Li, R. Martins, C. Rowe, T. Tomita, K. Matsuzaki, K. Ishii, K. Ishii, Y. Arahata, S. Iwamoto, K. Ito, K. Tanaka, C.L. Masters, and K. Yanagisawa, Nature(London), 554, 249 (2018). (APP669-711/Aβ1-42 in plasma as a biomarker for Alzheimer's disease)

Search other product
About Our Product
Technology


Scroll to top